Pharming Group N.V. (AMS:PHARM)
1.710
-0.070 (-3.93%)
At close: Jan 28, 2026
Pharming Group Employees
Pharming Group had 404 employees as of December 31, 2024. The number of employees increased by 22 or 5.76% compared to the previous year.
Employees
404
Change (1Y)
22
Growth (1Y)
5.76%
Revenue / Employee
€764,273
Profits / Employee
€806
Market Cap
1.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 404 | 22 | 5.76% |
| Dec 31, 2023 | 382 | 50 | 15.06% |
| Dec 31, 2022 | 332 | 55 | 19.86% |
| Dec 31, 2021 | 277 | 15 | 5.73% |
| Dec 31, 2020 | 262 | 50 | 23.58% |
| Jan 1, 2020 | 212 | 29 | 15.85% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Havas | 22,841 |
| Fugro | 9,527 |
| AMG Critical Materials | 3,651 |
| TomTom | 3,621 |
| Corbion | 2,431 |
| Ferrari Group | 2,084 |
| OCI N.V. | 1,091 |
| Acomo | 781 |
Pharming Group News
- 7 days ago - Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH):... • news - Onvista
- 20 days ago - Pharming Projects 27% Revenue Growth In 2025, Surpassing Prior Guidance, Driven By RUCONEST, Joenja - Nasdaq
- 20 days ago - Pharming Group reports preliminary 2025 revenues and announces Investor Day - GlobeNewsWire
- 7 weeks ago - Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit - GlobeNewsWire
- 2 months ago - Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade - Nasdaq
- 2 months ago - Pharming Group N.V. (PHAR) Presents at Jefferies London Healthcare Conference 2025 - Slideshow - Seeking Alpha
- 2 months ago - Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday - Benzinga
- 2 months ago - Earnings Estimates Moving Higher for Pharming Group (PHAR): Time to Buy? - Nasdaq